Melatonin hormone can help prevent cardiovascular disease risk in children born through ART

NewsGuard 100/100 Score

Studies are revealing that children born through assisted reproductive technologies (ART) have a higher risk of developing cardiovascular disease. The increased risk is due to changes in the expression of the genes important for vascular health. These studies suggest that the composition of the solutions in which embryo fertilization and culturing are done is to blame. A new study in the American Journal of Physiology—Heart and Circulatory Physiology reports that adding the hormone melatonin to the culture solution prevented the altered gene expression induced by ART in mice. Melatonin is involved in ovarian function and egg maturation and has been observed to improve fertilization success of ART. These findings support that elevated cardiovascular risk in children of ART can be prevented by modifying the embryo culture solution, the researchers wrote.

The study "Prevention of vascular dysfunction and arterial hypertension in mice generated by assisted reproductive technologies by addition of melatonin to culture media" is published ahead-of-print in the American Journal of Physiology—Heart and Circulatory Physiology.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Blood protein could be a potential biomarker for delayed concussion recovery in children